A district health officer in Uttar Pradesh is designing a screening program for anemia in pregnant women at the anganwadi level (grassroots ICDS worker). What is the most appropriate investigation of choice for initial detection and monitoring of anemia in this setting?

## Investigation of Choice for Anemia Screening at Grassroots Level ### Rationale for Hemoglobin Estimation by Portable Methods **Key Point:** Hemoglobin estimation using a portable hemoglobinometer or WHO color scale method is the investigation of choice for initial anemia screening in pregnant women at the anganwadi/grassroots level, as per Indian public health guidelines. ### Why Portable Hemoglobin Estimation is Optimal 1. **Feasibility**: Can be performed by ICDS workers with minimal training 2. **Cost-effectiveness**: Extremely low cost (₹5–10 per test) 3. **Point-of-care**: Results available immediately (no laboratory infrastructure needed) 4. **Sensitivity**: Adequate for population screening (>85% sensitivity) 5. **Sustainability**: Portable hemoglobinometer requires no electricity or complex equipment 6. **Public health impact**: Enables early identification and referral for treatment ### WHO Color Scale Method **Clinical Pearl:** The WHO color scale (hemoglobin color scale) is a simple, non-invasive method where a drop of blood is compared to a color chart. It is the most widely used method in anganwadis and primary health centers in India. **High-Yield:** Normal hemoglobin cutoff in pregnancy (WHO): **11 g/dL** (anemia if <11 g/dL). This is the threshold used for screening at grassroots level. ### Comparison of Investigations for Anemia Screening | Investigation | Sensitivity | Cost | Infrastructure | Feasibility at Anganwadi | Turnaround Time | | --- | --- | --- | --- | --- | --- | | Hemoglobin color scale | 85–90% | Very low | None | **Yes** | Immediate | | Portable hemoglobinometer | 90–95% | Low | Minimal | **Yes** | Immediate | | CBC with smear | 98%+ | Moderate | Laboratory | No | 24–48 hrs | | Serum ferritin/iron studies | Specific | High | Laboratory | No | 2–3 days | | Bone marrow biopsy | 100% | Very high | Specialized | No | 3–7 days | ### Limitations of Other Methods at Grassroots Level **Warning:** - **CBC with peripheral smear**: Requires laboratory infrastructure, trained technician, and 24–48 hour turnaround — not feasible for screening at anganwadi level. - **Serum ferritin/iron studies**: Are confirmatory investigations for iron deficiency etiology, not screening tools. They are expensive and require laboratory facilities. - **Bone marrow biopsy**: Is an invasive diagnostic procedure reserved for refractory anemia or suspected hematologic malignancy — absolutely inappropriate for screening. ### Screening and Referral Algorithm ```mermaid flowchart TD A[Pregnant woman at anganwadi]:::outcome --> B[Hemoglobin estimation<br/>by color scale/hemoglobinometer]:::action B --> C{Hb ≥ 11 g/dL?}:::decision C -->|Yes| D[Normal: Routine ANC<br/>Repeat at 28 weeks]:::action C -->|No| E[Anemia detected<br/>Hb < 11 g/dL]:::outcome E --> F[Refer to PHC/hospital]:::action F --> G[CBC + peripheral smear<br/>at PHC]:::action G --> H[Determine etiology<br/>Iron studies if indicated]:::action H --> I[Initiate treatment<br/>Iron supplementation]:::action ``` **Mnemonic:** **SCREEN** at grassroots — **S**imple test, **C**ost-effective, **R**apid results, **E**arly referral, **E**nable treatment, **N**o infrastructure. ### Role of Higher-Tier Investigations **Clinical Pearl:** CBC and peripheral smear are performed at PHC/hospital level for: - Confirmation of anemia - Determination of type (microcytic, normocytic, macrocytic) - Identification of other hematologic abnormalities - Guiding specific treatment Serum ferritin and iron studies are reserved for: - Confirming iron deficiency etiology - Assessing iron stores - Monitoring response to iron supplementation [cite:Park 26e Ch 6; ICDS Guidelines 2023]